Orchestra BioMed Holdings, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Orchestra BioMed Holdings, Inc. (OBIO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$24.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$24.08M.
- Orchestra BioMed Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$20.66M.
- Orchestra BioMed Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$19.36M.
- Orchestra BioMed Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-03-31 was -$18.75M.
- Orchestra BioMed Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$52.95M.
- Orchestra BioMed Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$61.02M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 7 month | Net Income (Loss) Available to Common Stockholders, Basic 7 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$24.08M 10-Q · filed 2026-08-10 | -$44.73M 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | -$20.66M 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | -$52.95M 10-K · filed 2026-03-12 | ||||
| 2025-06-30 | -$19.36M 10-Q · filed 2026-08-10 | -$38.12M 10-Q · filed 2026-08-10 | |||
| 2025-03-31 | -$18.75M 10-Q · filed 2026-05-12 | ||||
| 2024-12-31 | -$61.02M 10-K · filed 2026-03-12 | ||||
| 2021-03-31 | $108.00K 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $1.50M 10-K/A · filed 2022-03-31 | $174.00K 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |